众生药业
(002317)
| 流通市值：108.63亿 | | | 总市值：121.69亿 |
| 流通股本：7.62亿 | | | 总股本：8.53亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 954,601,790.51 | 1,252,043,320.29 | 1,611,345,350.7 | 1,593,461,397.69 |
| 结算备付金 | 0 | 0 | 0 | - |
| 拆出资金 | 0 | 0 | 0 | - |
| 衍生金融资产 | 0 | 0 | 0 | - |
| 应收票据及应收账款 | 1,214,479,264.39 | 978,293,306.04 | 1,027,912,573.39 | 1,095,605,207.37 |
| 其中：应收票据 | 726,792,847.02 | 497,755,507.56 | 468,344,491.92 | 509,634,828.46 |
| 应收账款 | 487,686,417.37 | 480,537,798.48 | 559,568,081.47 | 585,970,378.91 |
| 应收款项融资 | 3,200 | 3,200 | 0 | 1,102,754.02 |
| 预付款项 | 92,193,298.46 | 87,339,579.02 | 109,892,843.82 | 83,156,171.34 |
| 应收保费 | 0 | 0 | 0 | - |
| 应收分保账款 | 0 | 0 | 0 | - |
| 应收分保合同准备金 | 0 | 0 | 0 | - |
| 其他应收款合计 | 15,452,551.41 | 16,521,233.75 | 19,108,858 | 13,332,025.07 |
| 其中:应收利息 | 0 | 0 | 0 | - |
| 应收股利 | 0 | 0 | 0 | - |
| 买入返售金融资产 | 0 | 0 | 0 | - |
| 存货 | 490,500,491.65 | 520,393,304.89 | 541,888,080.53 | 536,186,572.71 |
| 合同资产 | 0 | 0 | 0 | - |
| 一年内到期的非流动资产 | 177,938,427.39 | 307,886,471.21 | 315,213,682.18 | 312,540,893.15 |
| 其他流动资产 | 114,575,292.07 | 115,066,036.01 | 55,905,279.28 | 48,819,366.98 |
| 流动资产其他项目 | 0 | 0 | - | - |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 3,566,392,507.42 | 3,960,606,763.22 | 4,031,824,565.79 | 3,859,334,085.03 |
| 非流动资产: | | | | |
| 发放委托贷款及垫款 | 0 | 0 | 0 | - |
| 债权投资 | 0 | 0 | 0 | - |
| 其他债权投资 | 0 | 0 | 0 | - |
| 长期应收款 | 0 | 0 | 0 | - |
| 长期股权投资 | 2,554,485.08 | 1,815,466.82 | 4,970,114.85 | 5,071,112.88 |
| 其他权益工具投资 | 123,039,292.97 | 122,334,252.37 | 127,607,828.45 | 127,682,275.36 |
| 其他非流动金融资产 | 34,765,000 | 34,765,000 | 27,730,000 | 27,730,000 |
| 投资性房地产 | 3,366,359.14 | 3,465,309.86 | 25,446,917.97 | 25,790,552.73 |
| 固定资产 | 557,191,498.92 | 569,098,281.27 | 567,450,355.14 | 571,275,870.22 |
| 在建工程 | 124,476,748.56 | 123,548,723.01 | 117,094,060.98 | 109,408,215.09 |
| 生产性生物资产 | 0 | 0 | 0 | - |
| 油气资产 | 0 | 0 | 0 | - |
| 使用权资产 | 2,685,103.77 | 3,262,552.02 | 3,840,000.27 | 4,417,448.52 |
| 无形资产 | 440,355,893.12 | 446,699,182.02 | 446,104,416.53 | 443,907,210.51 |
| 开发支出 | 559,788,107.95 | 538,349,981.64 | 477,081,778.99 | 464,310,192.7 |
| 商誉 | 208,626,197.09 | 208,626,197.09 | 208,626,197.09 | 208,626,197.09 |
| 长期待摊费用 | 2,925,751.32 | 3,363,868.47 | 4,001,233.41 | 4,638,598.32 |
| 递延所得税资产 | 43,852,229.31 | 42,447,640.12 | 46,084,495.33 | 48,907,520.26 |
| 其他非流动资产 | 555,415,768.53 | 400,139,181.18 | 334,183,300.73 | 317,459,275.48 |
| 非流动资产其他项目 | 0 | 0 | - | - |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 2,659,042,435.76 | 2,497,915,635.87 | 2,390,220,699.74 | 2,359,224,469.16 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 6,225,434,943.18 | 6,458,522,399.09 | 6,422,045,265.53 | 6,218,558,554.19 |
| 流动负债: | | | | |
| 短期借款 | 328,852,473.56 | 621,487,515.16 | 597,188,690 | 422,002,924.95 |
| 向中央银行借款 | 0 | 0 | 0 | - |
| 吸收存款及同业存放 | 0 | 0 | 0 | - |
| 拆入资金 | 0 | 0 | 0 | - |
| 交易性金融负债 | 0 | 0 | 0 | - |
| 衍生金融负债 | 0 | 0 | 0 | - |
| 应付票据及应付账款 | 111,086,333.1 | 93,784,128.75 | 100,974,784.13 | 119,154,963.98 |
| 其中：应付票据 | 9,000,000 | 9,000,000 | 6,608,458 | 11,058,200 |
| 应付账款 | 102,086,333.1 | 84,784,128.75 | 94,366,326.13 | 108,096,763.98 |
| 预收款项 | 76,800 | 0 | 0 | 31.85 |
| 合同负债 | 25,922,237.99 | 25,908,682.08 | 20,399,989.32 | 30,980,070.29 |
| 卖出回购金融资产款 | 0 | 0 | 0 | - |
| 应付手续费及佣金 | 0 | 0 | 0 | - |
| 应付职工薪酬 | 19,121,193.32 | 49,782,404.68 | 22,883,294.9 | 24,501,821.95 |
| 应交税费 | 53,004,216.88 | 52,650,725.11 | 58,879,819.93 | 45,482,223.78 |
| 其他应付款合计 | 145,324,215.69 | 122,777,966.37 | 122,018,098.03 | 189,391,491.43 |
| 其中:应付利息 | 0 | 0 | 0 | - |
| 应付股利 | 0 | 0 | 0 | - |
| 应付分保账款 | 0 | 0 | 0 | - |
| 保险合同准备金 | 0 | 0 | 0 | - |
| 代理买卖证券款 | 0 | 0 | 0 | - |
| 代理承销证券款 | 0 | 0 | 0 | - |
| 一年内到期的非流动负债 | 100,595,329.21 | 4,811,918.63 | 4,469,265.55 | 5,659,162.7 |
| 其他流动负债 | 41,989,640.16 | 44,110,937.4 | 8,506,479.32 | 11,230,538.65 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 825,972,439.91 | 1,015,314,278.18 | 935,320,421.18 | 848,403,229.58 |
| 非流动负债: | | | | |
| 长期借款 | 0 | 97,000,000 | 97,000,000 | 97,000,000 |
| 应付债券 | 0 | 0 | 0 | - |
| 优先股 | 0 | 0 | 0 | - |
| 永续债 | 0 | 0 | 0 | - |
| 租赁负债 | 638,283.69 | 1,301,733.4 | 2,172,207.35 | 2,594,099.7 |
| 长期应付款 | 644,749,509.06 | 637,610,021.23 | 632,170,478.9 | 589,965,300.91 |
| 长期应付职工薪酬 | 0 | 0 | 0 | - |
| 预计负债 | 0 | 0 | 0 | - |
| 递延收益 | 131,846,730.58 | 132,668,809.47 | 131,579,711.26 | 131,763,107.19 |
| 递延所得税负债 | 44,004,506.59 | 48,950,943.3 | 62,079,336.58 | 61,756,867.83 |
| 其他非流动负债 | 0 | 0 | 0 | - |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 821,239,029.92 | 917,531,507.4 | 925,001,734.09 | 883,079,375.63 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 1,647,211,469.83 | 1,932,845,785.58 | 1,860,322,155.27 | 1,731,482,605.21 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 853,350,477 | 853,350,477 | 853,350,477 | 853,400,477 |
| 其他权益工具 | 0 | 0 | 0 | - |
| 优先股 | 0 | 0 | 0 | - |
| 永续债 | 0 | 0 | 0 | - |
| 资本公积 | 1,809,946,141.26 | 1,807,101,297.43 | 1,813,085,039.4 | 1,815,042,212.88 |
| 减:库存股 | 67,140,772.71 | 67,140,772.71 | 67,140,772.71 | 67,399,772.71 |
| 其他综合收益 | 57,967,790.38 | 57,362,705.25 | 58,190,663.43 | 55,778,496.07 |
| 专项储备 | 0 | 0 | 0 | - |
| 盈余公积 | 321,501,033.58 | 321,501,033.58 | 303,138,449.88 | 303,138,449.88 |
| 一般风险准备 | 0 | 0 | 0 | - |
| 未分配利润 | 1,435,423,758.09 | 1,384,129,891.72 | 1,418,715,001.24 | 1,347,769,602.52 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 4,411,048,427.6 | 4,356,304,632.27 | 4,379,338,858.24 | 4,307,729,465.64 |
| 少数股东权益 | 167,175,045.75 | 169,371,981.24 | 182,384,252.02 | 179,346,483.34 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 4,578,223,473.35 | 4,525,676,613.51 | 4,561,723,110.26 | 4,487,075,948.98 |
| 负债和股东权益合计 | 6,225,434,943.18 | 6,458,522,399.09 | 6,422,045,265.53 | 6,218,558,554.19 |
| 公告日期 | 2024-04-23 | 2024-04-23 | 2023-10-31 | 2023-08-22 |
| 审计意见(境内) | | 标准无保留意见 | | |